We want to hear from pregnant women and women who have recently delivered (in the last 3 months) for the planning of a clinical trial, which aims to test heparin injections to an oral blood thinning medication after delivery.

We want to hear from women not at risk of blood clots.

A 1-hour focus group on TEAMS is planned, where we will discuss with you:
• the proposed trial planned,
• what improvements can be made,
• what, if any concerns you may have in taking part.

We want to learn from women who have had experience of injecting low molecular weight heparin after the birth of their baby to prevent blood clots, with planning a clinical trial, which plans to test heparin injections to an oral blood thinning medication after delivery.
A focus group on TEAMS is planned, where we will discuss with you:
• your experiences of injecting heparin,
• the proposed trial planned,
• what improvements can be made,
• and what concerns you would have in taking part.